Stroke as a complication of acute coronary syndrome: 
questions to the neurologist

Michał Arkuszewski; Katarzyna Rość-Bereza; Grzegorz Opala

eISSN: 1897-4252
ISSN: 1731-5530

Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

4/2011
vol. 8

Send email

Copy url:

abstract:

Stroke as a complication of acute coronary syndrome: questions to the neurologist

Michał Arkuszewski

,

Katarzyna Rość-Bereza

,

Grzegorz Opala

Kardiochirurgia i Torakochirurgia Polska 2011; 4: 534–538

Online publish date: 2011/12/28

View full text Get citation

Stroke is the most important cause of disability and one of the most important causes of death. About 1.40% of patients with acute coronary syndrome (ACS) suffer from stroke, of which about 2/3 are ischemic strokes. Intracranial hemorrhage is

a complication in about 1.43% of patients with myocardial infarction treated with thrombolysis. Dual antiplatelet therapy raises the risk of hemorrhagic complications, however it is not determined whether it raises the risk of intracranial hemorrhage. At present, there are no detailed guidelines for the management of patients with intracranial hemorrhage in the course of the dual antiplatelet therapy after ACS. Every patient with acute stroke should be treated in the stroke unit under supervision of the neurologist. At present, there are no recommendations for the routine use of any kind of neuroprotection in the stroke.

keywords:

Stroke as a complication of acute coronary syndrome: questions to the neurologist

Michał Arkuszewski , Katarzyna Rość-Bereza , Grzegorz Opala

stroke, cerebral hemorrhage, acute coronary syndrome, complication, antiplatelet treatment, treatment, neuroprotection

Michał Arkuszewski

,

Katarzyna Rość-Bereza

,

Grzegorz Opala